Dangerous bacterial infection hits highest level seen in Canada in more than a decade | More than 150 cases of invasive meningococcal disease in 20253. April 2026
News Neurent raises $74M to commercialize treatment for nasal conditionHealthradar12. Februar 2026 Dive Brief: Neurent Medical has raised 62.5 million euros ($74 million) to commercialize a device that treats a common nasal…
